NCT05548530 Prognostic Analysis of Different Treatment Options for Cerebral Hemorrhage
| NCT ID | NCT05548530 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Affiliated Hospital Of Guizhou Medical University |
| Condition | Brain Hemorrhage |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2014-01-01 |
| Primary Completion | 2027-03-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2014-01-01 with a primary completion date of 2027-03-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To analyze the influence of early hematoma morphology on hematoma expansion, optimize the treatment plan for cerebral hemorrhage, and guide the treatment of patients with cerebral hemorrhage in combination with clinical practice.
Eligibility Criteria
Inclusion Criteria: 1. Age 18-80 years old; 2. Intracerebral hemorrhage was diagnosed by head CT examination; Exclusion Criteria: 1. Multiple intracranial hemorrhage; 2. Intracranial hemorrhage caused by intracranial tumor, aneurysm, trauma, infarction or other lesions; 3. Coagulation disorders or a history of taking anticoagulants; 4. Infectious meningitis, systemic infection; 5. History of severe stroke, heart, kidney, liver and lung dysfunction in the past; 6. Severe brain herniation (mydriasis, respiratory and circulatory failure); 7. Incomplete or missing basic data or follow-up information in the hospital.
Contact & Investigator
Wu guofeng, Doctor
📞 13809431723
Frequently Asked Questions
Who can join the NCT05548530 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Brain Hemorrhage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05548530 currently recruiting?
Yes, NCT05548530 is actively recruiting participants. Visit ClinicalTrials.gov or contact The Affiliated Hospital Of Guizhou Medical University to inquire about joining.
Where is the NCT05548530 trial being conducted?
This trial is being conducted at Guiyang, China.
Who is sponsoring the NCT05548530 clinical trial?
NCT05548530 is sponsored by The Affiliated Hospital Of Guizhou Medical University. The trial plans to enroll 1,000 participants.